News

Gavin Ezekowitz, CIO at BFA Global Investors, says the industry must do a better job of managing liquidity events in unlisted funds.

In today's edition, Secondaries is on the up, though friction points remain; What's driving evergreen outperformance; Defence sees a deal deluge.

After a surge in interest around the covid-19 pandemic, it has been a mixed picture for life sciences and biotech-focused PE fundraising and capital deployment.

EQT Private Capital Asia returned $14bn to investors in 2025 alone, deputy co-head of private capital Asia Hari Gopalakrishnan tells PEI.

Investors are focusing more on the theme of resilience, David Kelnar of the investment bank's private capital team tells PEI.

Cross-fund investments are generally used for single-asset CVs as secondaries investors expect GPs to be 'as much all-in on trophy, crown-jewel assets as they possibly can be,' according to William Blair’s Tom Marking.

'Court Square has sent back $7.4bn to its LPs since 2022, the year the Fed began raising rates,' president and managing partner Chris Bloise tells Buyouts.

Private market exposure has enduring appeal for local government pension schemes; the heavy lifting now lies in integration, education and portfolio stewardship, sources tell PEI.

In today's edition, PE has a huge education gap among individual investors; Liquidity concerns, inexperienced managers fail to dent ELTIF enthusiasm; Another sector specialist targets the GP-led secondaries space.

Buyouts reported several items of good news in its Q1 report on private equity fundraising in North America that could portend important consequences for the industry down the line.